StockData
Biogen Inc. logo

Biogen Inc. (BIIB) stock

BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3056% above fair value
$251.41+0.62 (+0.25%)

Close on Nov 18, 2026Market cap $37.16BP/E 107.4Yield –

Biogen market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Biogen's market cap was $37.52B on Nov 11, 2026, against $26.68B a year earlier. Over the last 5 years it ranged from $17.65B to $44.72B, with a median of $31.13B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$37.52B+45.5%
2025Dec 31, 2025$25.78B+15.5%
2024Dec 31, 2024$22.32B-40.6%
2023Dec 29, 2023$37.58B-7.4%
2022Dec 30, 2022$40.58B+11.8%
2021Dec 31, 2021$36.29B-11.4%
2020Dec 31, 2020$40.98B-28.4%
2019Dec 31, 2019$57.26B-8.6%
2018Dec 31, 2018$62.66B-8.2%
2017Dec 29, 2017$68.25B+9.5%
2016Dec 30, 2016$62.31B-13.5%
2015Dec 31, 2015$72.01B-10.7%
2014Dec 31, 2014$80.61B+20.9%
2013Dec 31, 2013$66.67B+85.9%
2012Dec 31, 2012$35.87B+27.9%
2011Dec 30, 2011$28.05B+46.7%
2010Dec 31, 2010$19.12B+22.8%
2009Dec 31, 2009$15.58B–

More Biogen figures

See a number that looks wrong?